Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-26

Clinical Trial Update: EFFECTIVENESS OF ZINC AS AN ADJUVANT TO STANDARD THERAPY VERSUS STANDARD THERAPY ALONE IN CHILDREN [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zinc as an adjunct to standard therapy for asthma in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZINC (Zinc chloride)

Snippet

Sponsor: King Edward Medical University | Conditions: Asthma in Children | Phase 3 | Status: COMPLETED